우리는 구매한다 290 Peptide Overview

Generic and Brand Name: 우리는 구매한다 290 or Cibinetide is also referred to as pyroglutamate helix B surface peptide (pHBSP). There are no FDA-approved drugs in commercial use that contain this drug. It is commonly used in clinical trials as an experimental synthetic peptide, which is why it is mostly referred to as ARA 290 in scientific work.

Medication Class: Non-Erythropoietic Innate Repair Receptor (IRR) Agonist, EPO-Derived Anti-Inflammatory and Tissue-Protective Peptide, Metabolic Homeostasis Modulator

Chemical Description: 우리는 구매한다 290 is an 11-amino-acid synthetic peptide made from helix B region of human erythropoietin (EPO). This peptide has an N-terminal pyroglutamate form and it has been designed to remove the hematopoietic effect of EPO, while keeping the ability to protect certain organs. This peptide has a molecular weight of about 1257 Da and its solubility in water is quite high. It has also a good stability during enzymatic reactions in biological systems.

Mechanism of Action

Receptor Activation

우리는 구매한다 290 performs its biological function by interacting with innate repair receptor (IRR), which is a heteromer made from EPOR and β-common receptors (CD131). It acts differently from normal EPO as it does not bind homodimeric EPOR, causing, therefore, the absence of red blood cell activation. It does not react with known metabolic receptors like GLP-1, GIP or melanocortin receptors.The activation of IRR initiates anti-inflammatory, anti-apoptotic, and tissue regenerative pathways in the body, ensuring targeted regulation while preventing systemic interferences.

1.2 Metabolic and Physiological Effects

우리는 구매한다 290 provides various metabolic and physiological advantages thanks to its effectiveness in receptor speculation. It shields pancreatic cells against inflammation and oxidative stress, promotes insuline synthesis, and increases insulin sensitivity in tissues, leading to a reduction in diabetes symptoms. The peptide inhibits pro-inflammatory factors such as TNF-α and IL-6, minimizing inflammation, and regulating the energy metabolism process. Moreover, it mitigates negative effects of metabolic syndrome in patients suffering from sleep apnea.

2. Areas of Usage (Scientific Research)

우리는 구매한다 290 can be used solely within preclinical studies; it is not an approved compound for use in humans by the FDA.

Research in Type 2 Diabetes: The compound is extensively used in experimental research concentrating on protection mechanisms of pancreatic cells and improvement of insuline resistance.

Chronic Weight Management Research: The medication is utilized in obesity research aimed at enhancing its influences on the processes of obesity-related inflammation, metabolism, and fat distribution in the human body.Obstructive Sleep Apnea-Related Studies: This refers to the studies aimed at the exposure of intermittent hypoxia, systemic inflammation and metabolic imbalances that are caused by OSA and give proof about the importance of conducting research on OSA multi-system complications.

Research on Core of Tissues: It is regarded as a very important laboratory instrument that is used in research on the neuroprotection of the organs, their recovery and their chronic inflammatory pathology.

규정 준수 & 연구 면책조항

Ara 290 Peptide is for research use only and academic experimental purposes. It is not registered as a pharmaceutical drug, dietary supplement or an over-the-counter medicine and has no clinical use approval from the FDA, EMA or other regional medical regulatory body. The product cannot be used for human clinical diagnosis, treatment of disease, oral or intravenous administration as well as commercial off-label usage. All of the product details and research data is academic in nature and not intended as medical advice or to be construed as therapeutic claims. Local laws, institutional laboratory-management requirements, and ethical-research standards must be followed by all purchasers and researchers. 무단 불법 사용시 당사는 책임을 지지 않습니다., 제품의 부적절한 작동 또는 비연구 용도.